However, MAP3K8 is predominantly considered a tumor-promoting oncogene in several tumor types, such as breast cancer, colon cancer, renal cell carcinoma, endometrial cancer, gastric cancer, nasopharyngeal carcinoma, thymoma and lymphoma [20]. Here, MAP3K8 is linked to neoplasm.